Johnson & Johnson (JNJ): I Would "Love" If Trump Praised The Company, Says Jim Cramer
Johnson & Johnson (NYSE:JNJ) is one of the largest and most well-known pharmaceutical companies in the world.
Johnson & Johnson (JNJ)
Market is closed
Sector: Pharmaceutical Preparations
Hedge Fund Popularity
Hedge Fund Holdings
Filing Period: Filing is Ongoing
Last updated on based on SEC 13F filings Last update:
| No. | Hedge Fund | Shares | Value | Activity | % Port |
|---|---|---|---|---|---|
| 1. | Zevenbergen Capital Investments Nancy Zevenbergen | 10,739 | $1,640,382 | +4% | 0.03% |
Insider Trading: Purchases See All
| Insider | Price | Amount | Total Value | Remaining Holdings | Date | Form 4 |
|---|---|---|---|---|---|---|
| $145.53 | 100 | $14,553.00 | 250 | 2024-04-30 | Filing | |
| $147.22 | 1,000 | $147,220.00 | 1,000 | 2024-12-12 | Filing | |
| $127.69 | 500 | $63,843.00 | 16,030 | 2020-03-13 | Filing | |
| $141.28 | 5,000 | $706,399.00 | 5,000 | 2019-12-13 | Filing | |
| $139.68 | 3,000 | $419,040.00 | 3,000 | 2019-06-11 | Filing |
Insider Trading: Sales See All
| Insider | Price | Amount | Total Value | Remaining Holdings | Date | Form 4 |
|---|---|---|---|---|---|---|
| $165.88 | 6,999 | $1,160,994.12 | 21,001 | 2025-02-25 | Filing | |
| $156.15 | 403 | $62,928.45 | 15,098 | 2025-02-18 | Filing | |
| $153.89 | 13,015 | $2,002,878.35 | 0 | 2025-02-07 | Filing | |
| $165.06 | 5,635 | $930,113.10 | 18,973 | 2024-08-30 | Filing | |
| $162.16 | 8,891 | $1,441,764.56 | 15,043 | 2024-03-13 | Filing |
Institutional Investors' Holdings
Filing Period: Filing is Ongoing
| No. | Name | Shares | Value | % Port |
|---|---|---|---|---|
| 1. | 4,159,260 | $635,326,965 | 0.94% | |
| 2. | 2,008,649 | $306,821,140 | 0.34% | |
| 3. | 1,724,086 | $268,974,690 | 0.44% | |
| 4. | 632,425 | $96,602,898 | 1.4% | |
| 5. | 588,129 | $89,836,705 | 0.7% |
News See All
14 Stocks Jim Cramer Discussed As He Talked About Record Bitcoin Price
In a recent appearance on CNBC's Squawk on the Street, Jim Cramer discussed the recent Bitcoin price jumps.
Johnson & Johnson (JNJ) Declined Amid Broad Sell-Off in Healthcare
Mar Vista Investment Partners, LLC, an investment management company, released its “Mar Vista U.S. Quality Premier Strategy” second-quarter 2025 investor letter.
Johnson & Johnson Submits Schizophrenia Drug CAPLYTA sNDA to FDA Based on Positive Relapse Prevention Data
Johnson & Johnson (NYSE:JNJ) is one of the most undervalued NYSE stocks to buy now.
12 Most Undervalued NYSE Stocks to Buy Now
On July 8, Brenda Vingiello, Sand Hill Global Advisors' CIO joined 'Closing Bell Overtime' on CNBC to talk about the day's market action.
Johnson & Johnson (JNJ) Applied to the European Medicines Agency to Expand AKEEGA Usage
Johnson & Johnson (NYSE:JNJ) is one of the 10 Best Non-Tech Stocks to Buy and Hold For 3 Years. On July 3, Janssen-Cilag, a company of Johnson & Johnson (NYSE:JNJ), reported applying to the European...
10 Best Non-Tech Stocks to Buy and Hold For 3 Years
On July 4, Scott Bessent, US Treasury Secretary, gave a statement noting that the market resilience has shown that the tariffs haven’t hurt the economy.
J.P. Morgan Maintained Their Hold Rating on Johnson & Johnson (JNJ)
Johnson & Johnson (NYSE:JNJ) is one of the 10 Best Dip Stocks to Buy According to Billionaires. On June 26, J.P.
Goldman Sachs Rates Johnson & Johnson a Buy, Citing Pipeline Strength and Policy Tailwinds
Johnson & Johnson (NYSE:JNJ) ranks among the best set-it-and-forget-it stocks to buy.
10 Best Dip Stocks to Buy According to Billionaires
On July 3rd, Dan Ives, Global Head of Tech Research at Wedbush, joined CNBC to discuss the technology sector.
Billionaire Hedge Funds
